Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

CH Lee, CC Yu, BY Wang, WW Chang - Oncotarget, 2015 - pmc.ncbi.nlm.nih.gov
Cancer stem cells (CSCs) are a sub-population of cells within cancer tissues with tumor
initiation, drug resistance and metastasis properties. CSCs also have been considered as …

Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma

A Alisi, WC Cho, F Locatelli, D Fruci - International journal of molecular …, 2013 - mdpi.com
Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness
is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could …

Neuroblastoma patient‐derived orthotopic xenografts retain metastatic patterns and geno‐and phenotypes of patient tumours

N Braekeveldt, C Wigerup, D Gisselsson… - … journal of cancer, 2015 - Wiley Online Library
Neuroblastoma is a childhood tumour with heterogeneous characteristics and children with
metastatic disease often have a poor outcome. Here we describe the establishment of …

Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas

OA Elkashty, G Abu Elghanam, X Su, Y Liu… - …, 2020 - academic.oup.com
Head and neck squamous cell carcinoma (HNSCC) has a poor 5-year survival rate of 50%.
One potential reason for treatment failure is the presence of cancer stem cells (CSCs) …

Cancer stem cells in neuroblastoma: expanding the therapeutic frontier

HF Bahmad, F Chamaa, S Assi… - Frontiers in molecular …, 2019 - frontiersin.org
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in
childhood. Despite intense efforts to develop a successful treatment, current available …

[HTML][HTML] LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma

GC Vieira, S Chockalingam, Z Melegh, A Greenhough… - Oncotarget, 2015 - ncbi.nlm.nih.gov
LGR5 is a marker of normal and cancer stem cells in various tissues where it functions as a
receptor for R-spondins and increases canonical Wnt signalling amplitude. Here we report …

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours

FM Vega, A Colmenero-Repiso, MA Gómez-Muñoz… - …, 2019 - thelancet.com
Background Neuroblastoma is a paediatric tumour originated from sympathoadrenal
precursors and characterized by its heterogeneity and poor outcome in advanced stages …

Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma

M Flahaut, N Jauquier, N Chevalier, K Nardou… - BMC cancer, 2016 - Springer
Background The successful targeting of neuroblastoma (NB) by associating tumor-initiating
cells (TICs) is a major challenge in the development of new therapeutic strategies. The …

[HTML][HTML] Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours

LT Bate-Eya, ME Ebus, J Koster, IJM den Hartog… - European journal of …, 2014 - Elsevier
Recently protocols have been devised for the culturing of cell lines from fresh tumours under
serum-free conditions in defined neural stem cell medium. These cells, frequently called …

Patient-derived models: Advanced tools for precision medicine in neuroblastoma

K Aaltonen, K Radke, A Adamska, A Seger… - Frontiers in …, 2023 - frontiersin.org
Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-
risk neuroblastoma patients have a poor overall survival and account for~ 15% of childhood …